For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
National Review
Was the U.S. furtively funding the lab research that unleashed Covid-19?
Slowly but surely, new cracks are appearing in the wall of silence denying Chinese culpability in causing the nearly 7 million deaths attributed to…
Blog
Covid Lockdowns Did Not Improve Outcomes: Lessons from Florida and California
My Competitive Enterprise Institute colleague Dr. Joel Zinberg is the co-author of a new report, published by the Paragon Health Institute titled “Freedom Wins:…
National Review
Fauci Changes His Public Tune on Covid Vaccines
Dr. Anthony Fauci has finally acknowledged that there had always been good scientific reasons to believe that vaccines against the respiratory…
Search Posts
City Journal
A Pox By Any Other Name
Anyone wondering why medical authorities seem so ineffectual need look no further than their newfound obsession with renaming the monkeypox virus and the disease it…
National Review
Monkeypox Outbreak Leveling Off, No Thanks to Government
Something that apparently surprised government bureaucrats and left-wing commentators but is, in fact, completely predictable is happening: The growth in new monkeypox cases is leveling off…
The New York Post
Key to CDC reform is undoing mission creep — and tossing woke programs
Centers for Disease Control and Prevention Director Rochelle Walensky has finally admitted what has been obvious to most observers for 2½ years: The agency has been…
C-SPAN
Video: Senior Fellow Joel Zinberg Joins C-SPAN to Discuss Senate Democratic Health Care and Prescription Drug Proposals
Senior Fellow Joel Zinberg joined the Washington Journal to discuss Senate Democratic Health Care and Prescription Drug Proposals. Click here to read more.
City Journal
No More Masks
Covid-19 cases are on the rise again in the United States. Even President Biden is infected. But the biggest danger is not the virus—the now-dominant…
National Review
Regulators’ Misguided Crackdown on Nicotine Products and Their Makers
Federal agencies must really love black markets. Last week, the Food and Drug Administration (FDA) announced a plan to limit nicotine in cigarettes and …
